CNBC's Angelica Peebles reports the latest news surrounding pharmaceutical markets.
Breakdown
- White House drafting tariffs up to 100% on branded pharmaceuticals 6s
- Companies with administration deals are exempt from tariffs 27s
- Generic and orphan drugs also exempt from tariffs 37s
- Onshoring companies face 20% tariff, rising to 100% in four years 42s
- Separate rates set for EU, Japan, South Korea, Switzerland, and UK 50s